ADC Therapeutics SA (ADCT)

ADC Therapeutics Revenue

ADC Therapeutics had revenue of $16.43M in the quarter ending September 30, 2025, a decrease of -11.03%. This brings the company's revenue in the last twelve months to $75.21M, up 6.35% year-over-year. In the year 2024, ADC Therapeutics had annual revenue of $70.84M with 1.84% growth.

• Revenue (ttm): $75.21M
• Revenue Growth: +6.35%
• P/S Ratio: 6.80
• Revenue / Employee: $283,808
• Employees: 265
• Market Cap: 506.04M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	70.84M	1.28M	1.84%
Dec 31, 2023	69.56M	-140.35M	-66.86%
Dec 31, 2022	209.91M	175.99M	518.89%
Dec 31, 2021	33.92M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	2.34M	1.20M	105.26%
Dec 31, 2018	1.14M	-663.00K	-36.77%
Dec 31, 2017	1.80M	-	-